- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01196442
Electrical Stimulation Pain Therapy in Treating Chronic Pain and Numbness Caused By Chemotherapy in Patients With Cancer
An Expanded Trial of MC5-A Calmare Therapy in the Treatment of Cancer Pain Syndromes and Chronic Chemotherapy-Induced Peripheral Neuropathy Including Pain and Numbness
Study Overview
Status
Intervention / Treatment
Detailed Description
OBJECTIVES:
I. To evaluate the effect of MC5-A on pain symptoms both immediately and over time.
II. To evaluate the effect of Calmare therapy on other non-pain symptoms. III. To evaluate the effect of MC5-A on daily opioid and other pain medication use.
OUTLINE: Patients undergo electric stimulation pain therapy comprising MC5-A Calmare therapy over 30 minutes once daily for 10 days. After completion of study treatment, patients are followed up for 3 months.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Virginia
-
Richmond, Virginia, United States, 23298
- Virginia Commonwealth University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- CIPN neuropathy: received, or currently receiving, neurotoxic chemotherapy (including taxanes-such as paclitaxel or docetaxel, or platinum-based compounds such as carboplatin or cis-platinum or oxaliplatin, or vinca alkaloids such as vincristine, vinblastine, or vinorelbine, or proteosome inhibitors such as bortezomib)
- Pain or symptoms of peripheral neuropathy of >= 1 months duration attributed to chemotherapy-induced peripheral neuropathy
- OR pain of the other types including chemotherapy-induced peripheral neuropathy, numbness predominant; post mastectomy pain; post surgical pain; post herpetic neuropathy; post radiation pain; other (vertebral compression, fracture, miscellaneous)
- The pain must have been stable for at least 2 weeks
- An average daily pain rating of >= 5 out of 10, using the pain numerical rating scale (NRS: 0 is no pain and 10 is worst pain possible); or numbness that bothers the patient at least "a little bit" on the CIPN-20
- Life expectancy >= 3 months
- ECOG performance status 0, 1, or 2
Exclusion Criteria:
- Pregnant women, nursing women, women of childbearing potential or their sexual partners who are unwilling to employ adequate contraception (condoms, diaphragm, birth control pills, injections, intrauterine device [IUD], surgical sterilization, subcutaneous implants, abstinence, etc.)
- Use of an investigational agent for pain control concurrently or =< 30 days
- History of an allergic reaction or previous intolerance to transcutaneous electronic nerve stimulation
- Patients with implantable drug delivery systems, e.g., Medtronic Synchromed
- Patients with heart stents or metal implants such as pacemakers, automatic defibrillators, aneurysm clips, vena cava clips and skull plates (metal implants for orthopedic repair, e.g., pins, clips, plates, cages, joint replacements are allowed)
- Patients with a history of myocardial infarction or ischemic heart disease within the past six months
- Patients with history of epilepsy, brain damage, use of anti-convulsants, symptomatic brain metastases
- Prior celiac plexus block, or other neurolytic pain control treatment within 4 weeks
- Other identified causes of painful paresthesias existing prior to chemotherapy (e.g., radiation or malignant plexopathy, lumbar or cervical radiculopathy, pre-existing peripheral neuropathy of another etiology: B12 deficiency, AIDS, monoclonal gammopathy, diabetes, heavy metal poisoning amyloidosis, syphilis, hyperthyroidism or hypothyroidism, inherited neuropathy)
- Skin conditions such as open sores that would prevent proper application of the electrodes
- Other medical or other condition(s) that in the opinion of the investigators might compromise the objectives of the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Arm I electric stimulation pain therapy
Patients undergo electric stimulation pain therapy comprising MC5-A Calmare therapy over 30 minutes once daily for 10 days.
|
Electrical stimulation pain therapy for 45 minutes on Day 1, then 30 minutes Days 2-10
Other Names:
Brief Pain Inventory questionnaire administration at baseline, weekly, then monthly for 3 months
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Pain Score From Day 1 to Day 10
Time Frame: From day 1 to day 10
|
Change in Brief Pain Inventory (Now)Scale 1 (none) to 5 (complete interference) |
From day 1 to day 10
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Effect of Electrical Stimulation Pain Therapy on Other Non-pain Symptoms at Day 1
Time Frame: Day 1
|
Chemotherapy-induced peripheral neuropathy (CIPN)-20.
The CIPN-20 has 3 subscales: a sensory, motor, and autonomic subscale.
There are 17 questions that are rated 0-not at all to 3-very much.
Scales are summed.
Final score ranges from 0-51, 0 as the best possible outcome and 51 as the worst.
|
Day 1
|
Use of Medications Including Morphine Oral Dose Equivalents, Anti-depressants, and Neuroleptics
Time Frame: From day 1 to day 30
|
Record daily pain medication usage and convert all opioids to MOEDs (American Pain Society 2003).
Compare the average daily use prior to day 1 to the average daily use day 30.
Range is 0-none to 240-most
|
From day 1 to day 30
|
Effect of Electric Stimulation Pain Therapy on Other Non-pain Symptoms at Day 10
Time Frame: Day 10
|
Chemotherapy-induced peripheral neuropathy (CIPN)-20.
The CIPN-20 has 3 subscales: a sensory, motor, and autonomic subscale.
There are 17 questions that are rated 0-not at all to 3-very much.
Scales are summed.
Final score ranges from 0-51, 0 as the best possible outcome and 51 as the worst.
|
Day 10
|
Effect of Electric Stimulation Pain Therapy on Other Non-pain Symptoms at Month 1
Time Frame: month 1
|
Chemotherapy-induced peripheral neuropathy (CIPN)-20.
The CIPN-20 has 3 subscales: a sensory, motor, and autonomic subscale.
There are 17 questions that are rated 0-not at all to 3-very much.
Scales are summed.
Final score ranges from 0-51, 0 as the best possible outcome and 51 as the worst.
|
month 1
|
Effect of Electric Stimulation Pain Therapy n Other Non-pain Symptoms at Month 2
Time Frame: month 2
|
Chemotherapy-induced peripheral neuropathy (CIPN)-20.
The CIPN-20 has 3 subscales: a sensory, motor, and autonomic subscale.
There are 17 questions that are rated 0-not at all to 3-very much.
Scales are summed.
Final score ranges from 0-51, 0 as the best possible outcome and 51 as the worst.
|
month 2
|
Effect of Electric Stimulation Pain Therapy on Other Non-pain Symptoms at Month 3
Time Frame: Month 3
|
Chemotherapy-induced peripheral neuropathy (CIPN)-20.
The CIPN-20 has 3 subscales: a sensory, motor, and autonomic subscale.
There are 17 questions that are rated 0-not at all to 3-very much.
Scales are summed.
Final score ranges from 0-51, 0 as the best possible outcome and 51 as the worst.
|
Month 3
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Craig Swainey, MD, Virginia Commonwealth University
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MCC-13098
- NCI-2010-01945 (Registry Identifier: CTRP)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pain
-
Flowonix MedicalApproved for marketingBack Pain | Leg Pain | Trunk Pain | Intractable Pain | Arm Pain
-
University Hospital Schleswig-HolsteinZealand University Hospital; European Regional Development Fund; Design School...CompletedPain, Acute | Pain, Chronic | Pain Measurement | Pain, CancerGermany
-
Universitat Jaume ICompletedPain, Acute | Pain, Chronic | OncologySpain
-
Dr. Negrin University HospitalCompletedPostoperative Pain, Acute | Postoperative Pain, ChronicSpain
-
George Washington UniversityRecruitingCervical Fusion | Pain, Back | Pain, Neck | Myofacial PainUnited States
-
University of Campinas, BrazilCompletedPREGNANCY | LUMBAR BACK PAIN | PELVIC PAIN
-
Dow University of Health SciencesRecruitingLow Back Pain | Chronic Low-back Pain | Low Back Pain, Mechanical | Mechanical Low Back Pain | Pain, Chronic | Pain, Back | Lower Back Pain Chronic | CLBP - Chronic Low Back PainPakistan
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Postoperative Pain, Acute | Postoperative Pain, Chronic | VATSTurkey
-
Janssen Research & Development, LLCCompletedPain, Radiating | Pain, Burning | Pain, Crushing | Pain, Migratory | Pain, SplittingUnited States, France, Spain, Poland, Portugal
-
susanne beckerSNSFCompletedLow Back Pain | Pain, Acute | Pain, ChronicSwitzerland
Clinical Trials on electrical stimulation pain therapy
-
Josue Fernandez CarneroRecruitingKnee OsteoarthritisSpain
-
Marco Aurélio Vaz, PhDFundação de Amparo à Pesquisa do Estado do Rio Grande do Sul, Brazil; Conselho...CompletedKnee OsteoarthritisBrazil
-
Universidad de ExtremaduraRecruitingPain Management | Ankylosing Spondylitis | Exercise Therapy | Physical Therapy Modalities | SpondyloarthropathiesSpain
-
Centre Hospitalier Universitaire, AmiensRecruitingEpilepsy | Children | tDCS | Transcranial Electric Stimulation | Pharmacoresistant | HR EEGFrance
-
University Health Network, TorontoWings for LifeActive, not recruiting
-
Universidad de AlmeriaCompletedFibromyalgia | Trigger PointsSpain
-
Toronto Rehabilitation InstituteRick Hansen Foundation; Ontario Neurotrauma FoundationTerminatedSpinal Cord InjuryCanada
-
University of Sao Paulo General HospitalCompleted
-
Federal University of São PauloCompleted
-
IRCCS San Camillo, Venezia, ItalyRecruiting